Pharmaceutical Care and Quality of Life in Conditions Related to Psychotropic Drug Use

N/AActive Not RecruitingNCT06889636

University of Rijeka97 enrolled

Overview

This study aims to assess and describe the impact of pharmaceutical care on identified drug-related problems (DRPs) in subjects using psycholeptics and psychoanaleptics in primary care, improving subjects' self-assessed quality of life (QoL) The hypothesis of the study are: 1. Side-effects are the most common DRPs in subjects using psychotropic medicines in primary care, 2. Treatment effectiveness and safety affect the subjects´ QoL

The study objectives are to: 1. assess QoL in subjects using psycholeptics and psychoanaleptics, 2. analyze identified DRPs and their causes in subjects using psycholeptics and psychoanaleptics 3. evaluate the correlation between the type and total number of DRPs identified in a single subject with QoL, 4. describe the impact of pharmacists´ intervention in the identification and resolution of the DRPs and their causes on subjects´ QoL.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Mental Health Services

Interventions

Pharmaceutical care in solving drug-related problems in subjects using psychotropic medicines based on standardized protocol..OTHER

Pharmacists' interventions were based on Medication Review and Medication Therapy Management evaluations of a subjects' pharmacotherapy to optimize medicine use, improve treatment outcomes and quality of life. The intervention involved the identification of drug-related problems and addressing these issues through pharmacist interventions. The intervention was based on information gathered from the subjects and a list of medicines in use.

Common pharmacists' practice in Croatia.OTHER

Group B participants received pharmaceutical care based on common pharmacists' practice in Croatia during the dispensing of psychotropic drugs.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult participants (years 18+) * Usage of psycholeptic or psychoanaleptic medicines * Residence in Istrian County (Croatia) Exclusion Criteria: * Minor participants * Hospitalization during study participation * Unable to live by themselves * Unable to participate in study for 3 months

Locations (1)

Pharmacy Bobanovic Vujnovic Pula

Pula, Croatia

Outcomes

Primary Outcomes

Assessment of the quality of life in subjects using psycholeptics and psychoanaleptics

A short version of the World Health Organization's quality of life questionnaire (WHOQOL-BREF questionnaire) is being used to assess subjects' QoL. The scale range is from 0 to 100. A higher score number indicates better QoL.

Time frame: Prior and after the pharmacists' intervention during three months period.

Secondary Outcomes

Analysis of identified drug-related problems

To analyze the type of DRPs, validated Classification for Drug-Related Problems from the Pharmaceutical Care Network Europe Association, version 9.1 has been used. PCNE Classification for DRPs describes each type of DRP by unique code.

Time frame: During period of three months.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.